Chad Therapeutics, Chatsworth, Calif., recorded a net loss of $683,000, or 7 cents a share, for the third quarter ended Dec. 31, compared with a loss of $894,000, or 9 cents a share, the same quarter the previous year.

Thomas Jones, chief executive officer, said that sales of the Oxymatic conserver continued to be affected by competitive factors and the 30 percent reduction in Medicare reimbursement over the last two years. He also noted the company is developing two new products designed to regain market share in the conserver arena.

Sharps Compliance Houston, posted a net loss of $379,000, or 5 cents a share, for the fiscal 2000 second quarter ended Dec. 31, an 8 percent increase compared with a net loss of $415,000, or 5 cents a share, for the same quarter last year.

For the six-month period, the company recorded a net loss of $701,000, or 9 cents a share, a 19 percent improvement compared with a net loss of $866,000, or 11 cents a share, a year ago.

Sharps' chief financial officer Kent Manby commented, "We were able to narrow our operating loss by 23 percent, despite substantially higher investments in marketing and sales programs designed to realize the potential of our systems and services within the home health care industry."

I-Flow Corp., Lake Forest, Calif., reported net income of $6.3 million, or 41 cents a diluted share, for the fourth quarter of 1999 ended Dec. 31, compared with net income of $576,000, or 4 cents a diluted share, for the same quarter the previous year.

For the 12-month period, the company posted net income of $8.8 million, or 58 cents a diluted share, compared with $1.1 million, or 8 cents a diluted share, a year ago.